Studies have showed that activation of the telomerase and inactivation of p53 is frequently detected in human cancers, and the overexpression of wild-type p53 can transcriptionally reduce the expression level of telomerase in various cancer cell lines (Xu et al., 2000). The gene discussed is TP53; the disease is cancer.